speb/financial-data huggingface dataset:
CNP balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 759000000.00
CNP income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 10000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 640000000.00
CNP income_statement (quarterly, 2025-03-31) — Other Taxes: 154000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Payables: 1244000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1479000000.00
CNP cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: -63000000.00
CNP income_statement (quarterly, 2025-03-31) — Pretax Income: 378000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Receivables: 1353000000.00
CNP income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1754000000.00
CNP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 363000000.00
CNP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -14000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1869000000.00
CNP cash_flow (quarterly, 2025-03-31) — Sale Of Business: 1219000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Share Issued: 652726920.00
CNP cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 569000000.00
CNP cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -3000000.00
CNP income_statement (quarterly, 2025-03-31) — Special Income Charges: -43000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10955000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7012000000.00
CNP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -9030000.00
CNP income_statement (quarterly, 2025-03-31) — Tax Provision: 81000000.00
CNP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CNP balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 81000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Assets: 44486000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 31317000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Debt: 22187000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10955000000.00
CNP income_statement (quarterly, 2025-03-31) — Total Expenses: 2271000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 33531000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 40350000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 29090000000.00
CNP income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 649000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 202000000.00
CNP income_statement (quarterly, 2025-03-31) — Total Unusual Items: -43000000.00
CNP income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -43000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 166.00
CNP balance_sheet (quarterly, 2025-03-31) — Working Capital: -305000000.00
CNP income_statement (quarterly, 2025-06-30) — +Operating Expense: 510000000.00
CNP income_statement (quarterly, 2025-06-30) — +Total Revenue: 1944000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 903000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 798000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -10790000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 9107000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -28000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
CNP income_statement (quarterly, 2025-06-30) — Basic Average Shares: 653000000.00
CNP income_statement (quarterly, 2025-06-30) — Basic EPS: 0.30
CNP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1259000000.00
CNP cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1129000000.00
CNP cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -1129000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 93000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 776000000.00
CNP cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -144000000.00
CNP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -613000000.00
CNP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1107000000.00
CNP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 560000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -114000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Inventory: -86000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -125000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Payable: -114000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -114000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Receivables: 409000000.00
CNP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 44000000.00
CNP cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 339000000.00
CNP cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1160000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Common Stock: 6000000.00
CNP cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -144000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 11019000000.00
CNP cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CNP income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1017000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 277000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Assets: 2930000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Debt: 1054000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1054000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 95000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 95000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3695000000.00
CNP cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 29000000.00
CNP cash_flow (quarterly, 2025-06-30) — Deferred Tax: 29000000.00
CNP cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 370000000.00
CNP income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 370000000.00
CNP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 370000000.00
CNP income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 370000000.00
CNP income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 654000000.00
CNP income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.30
CNP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 198000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 0.00
CNP income_statement (quarterly, 2025-06-30) — EBIT: 448000000.00
CNP income_statement (quarterly, 2025-06-30) — EBITDA: 818000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 477000000.00
CNP cash_flow (quarterly, 2025-06-30) — End Cash Position: 99000000.00
CNP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -613000000.00
CNP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -569000000.00
CNP income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
CNP income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -17000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Goodwill: 3943000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 3943000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 826000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Gross PPE: 44691000000.00
CNP income_statement (quarterly, 2025-06-30) — Gross Profit: 927000000.00
CNP income_statement (quarterly, 2025-06-30) — Interest Expense: 195000000.00
CNP income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 195000000.00
CNP cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 197000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Interest Payable: 277000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Inventory: 694000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 32637000000.00
CNP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1107000000.00
CNP cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CNP cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 557000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 20564000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 20564000000.00
CNP cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 70000000.00
CNP cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1019000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CNP cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CNP balance_sheet (quarterly, 2025-06-30) — Net Debt: 21525000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 198000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 198000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Interest Income: -195000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -462000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -949000000.00
CNP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -195000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -7000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 22000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Net PPE: 33901000000.00
CNP cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 487000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 7076000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4518000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4518000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 477000000.00
CNP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 817000000.00
CNP income_statement (quarterly, 2025-06-30) — Normalized Income: 197220000.00
CNP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 560000000.00
CNP cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1000000.00
CNP income_statement (quarterly, 2025-06-30) — Operating Income: 417000000.00
CNP income_statement (quarterly, 2025-06-30) — Operating Revenue: 1944000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 652814271.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 269000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1054000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1149000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -17000000.00
CNP income_statement (quarterly, 2025-06-30) — Other Income Expense: 31000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Inventories: 140000000.00
CNP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -80000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 237000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 843000000.00
CNP income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 30000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 683000000.00
CNP income_statement (quarterly, 2025-06-30) — Other Taxes: 140000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Payables: 1120000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1397000000.00
CNP income_statement (quarterly, 2025-06-30) — Pretax Income: 253000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Receivables: 1191000000.00
CNP income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1017000000.00
CNP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 370000000.00
CNP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1019000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1923000000.00
CNP cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CNP balance_sheet (quarterly, 2025-06-30) — Share Issued: 652814437.00
CNP cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 487000000.00
CNP cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
CNP income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CNP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 11019000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7076000000.00
CNP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 220000.00
CNP income_statement (quarterly, 2025-06-30) — Tax Provision: 55000000.00
CNP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
CNP balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 51000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Assets: 44099000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 31583000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Debt: 21618000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 11019000000.00
CNP income_statement (quarterly, 2025-06-30) — Total Expenses: 1527000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 33080000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 41169000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 29385000000.00
CNP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 417000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 217000000.00
CNP income_statement (quarterly, 2025-06-30) — Total Unusual Items: 1000000.00
CNP income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 1000000.00
CNP balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 166.00
CNP balance_sheet (quarterly, 2025-06-30) — Working Capital: -765000000.00
CNP income_statement (quarterly, 2025-09-30) — +Operating Expense: 525000000.00
CNP income_statement (quarterly, 2025-09-30) — +Total Revenue: 1988000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 968000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 787000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -11031000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 9119000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -22000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
CNP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 653000000.00
CNP income_statement (quarterly, 2025-09-30) — Basic EPS: 0.45
CNP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 99000000.00
CNP cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1222000000.00
CNP cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1222000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 37000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 616000000.00
CNP cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -144000000.00
CNP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 465000000.00
CNP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1261000000.00
CNP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 742000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 59000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Inventory: -88000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 299000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Payable: 59000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 59000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Receivables: -199000000.00
CNP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 71000000.00
CNP cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -191000000.00
CNP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -54000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Common Stock: 6000000.00
CNP cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -144000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 11035000000.00
CNP cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CNP income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 961000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 247000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Assets: 2949000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Debt: 2903000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2903000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 95000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 95000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5743000000.00
CNP cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 10000000.00
CNP cash_flow (quarterly, 2025-09-30) — Deferred Tax: 10000000.00
CNP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 392000000.00
CNP income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 392000000.00
CNP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 392000000.00
CNP income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 392000000.00
CNP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 656000000.00
CNP income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.45
CNP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 293000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 144000000.00
CNP income_statement (quarterly, 2025-09-30) — EBIT: 529000000.00
CNP income_statement (quarterly, 2025-09-30) — EBITDA: 921000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 460000000.00
CNP cash_flow (quarterly, 2025-09-30) — End Cash Position: 45000000.00
CNP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 465000000.00
CNP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -480000000.00
CNP cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -1000000.00
CNP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 0.00
CNP income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -19000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Goodwill: 3943000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3943000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 809000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 45578000000.00
CNP income_statement (quarterly, 2025-09-30) — Gross Profit: 1027000000.00
CNP income_statement (quarterly, 2025-09-30) — Interest Expense: 243000000.00
CNP income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 243000000.00
CNP cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 276000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Interest Payable: 247000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Inventory: 782000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 33338000000.00
CNP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1261000000.00
CNP cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CNP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1061000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 19400000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 19400000000.00
CNP cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2117000000.00
CNP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -448000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CNP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CNP balance_sheet (quarterly, 2025-09-30) — Net Debt: 22266000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 293000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 293000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Interest Income: -243000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 613000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1669000000.00
CNP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -243000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -4000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -39000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Net PPE: 34547000000.00
CNP cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1056000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 7092000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 4546000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 4546000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 460000000.00
CNP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 920000000.00
CNP income_statement (quarterly, 2025-09-30) — Normalized Income: 292210000.00
CNP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 742000000.00
CNP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1000000.00
CNP income_statement (quarterly, 2025-09-30) — Operating Income: 502000000.00
CNP income_statement (quarterly, 2025-09-30) — Operating Revenue: 1988000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 652865523.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 257000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 2903000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1111000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -19000000.00
CNP income_statement (quarterly, 2025-09-30) — Other Income Expense: 27000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Inventories: 233000000.00
CNP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -23000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 239000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 780000000.00
CNP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 26000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 579000000.00
CNP income_statement (quarterly, 2025-09-30) — Other Taxes: 133000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Payables: 1387000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1634000000.00
CNP income_statement (quarterly, 2025-09-30) — Pretax Income: 286000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Receivables: 1294000000.00
CNP income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 961000000.00
CNP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 392000000.00
CNP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -448000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1929000000.00
CNP cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CNP balance_sheet (quarterly, 2025-09-30) — Share Issued: 652865689.00
CNP cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
CNP income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CNP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11035000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 7092000000.00
CNP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 210000.00
CNP income_statement (quarterly, 2025-09-30) — Tax Provision: -7000000.00
CNP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CNP balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 59000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Assets: 45049000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 30435000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Debt: 22303000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11035000000.00
CNP income_statement (quarterly, 2025-09-30) — Total Expenses: 1486000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 34014000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 42100000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28271000000.00
CNP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 502000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 275000000.00
CNP income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1000000.00
CNP income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1000000.00
CNP balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 166.00
CNP balance_sheet (quarterly, 2025-09-30) — Working Capital: -2794000000.00
CNP income_statement (annual, 2025-12-31) — +Operating Expense: 2106000000.00
CNP income_statement (quarterly, 2025-12-31) — +Operating Expense: 554000000.00
CNP income_statement (annual, 2025-12-31) — +Total Revenue: 9357000000.00
CNP income_statement (quarterly, 2025-12-31) — +Total Revenue: 2505000000.00
CNP balance_sheet (annual, 2025-12-31) — Accounts Payable: 1300000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1300000000.00
CNP balance_sheet (annual, 2025-12-31) — Accounts Receivable: 806000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 806000000.00
CNP balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10620000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10620000000.00
CNP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 9130000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 9130000000.00
CNP balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -25000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -25000000.00
CNP cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 274000000.00
CNP cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 274000000.00
CNP balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 2669000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 2669000000.00
CNP income_statement (annual, 2025-12-31) — Basic Average Shares: 653000000.00
CNP income_statement (annual, 2025-12-31) — Basic EPS: 1.61
CNP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 30000000.00
CNP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 45000000.00
CNP cash_flow (annual, 2025-12-31) — Capital Expenditure: -4870000000.00
CNP cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1481000000.00
CNP cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -4870000000.00
CNP cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -1481000000.00
CNP balance_sheet (annual, 2025-12-31) — Capital Stock: 6000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6000000.00
CNP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 38000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 38000000.00
CNP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 548000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 548000000.00
CNP cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -574000000.00
CNP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -143000000.00
CNP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1549000000.00
CNP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 644000000.00
CNP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4016000000.00
CNP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1414000000.00
CNP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2486000000.00
CNP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 774000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Account Payable: -15000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 256000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Inventory: -17000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Inventory: 47000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 15000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 221000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Payable: -15000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Payable: 256000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -15000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 256000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Receivables: -253000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Receivables: -338000000.00
CNP cash_flow (annual, 2025-12-31) — Change In Working Capital: -49000000.00
CNP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 112000000.00
CNP cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -253000000.00
CNP cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -276000000.00
CNP cash_flow (annual, 2025-12-31) — Changes In Cash: 19000000.00
CNP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4000000.00
CNP balance_sheet (annual, 2025-12-31) — Common Stock: 6000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Common Stock: 6000000.00
CNP cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -574000000.00
CNP cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -143000000.00
CNP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 11153000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 11153000000.00
CNP cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CNP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CNP income_statement (annual, 2025-12-31) — Cost Of Revenue: 5141000000.00
CNP income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1409000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 313000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 313000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Assets: 5701000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Assets: 5701000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Debt: 2414000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Debt: 2414000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2414000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2414000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 89000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 89000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 89000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 89000000.00
CNP balance_sheet (annual, 2025-12-31) — Current Liabilities: 6260000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6260000000.00
CNP cash_flow (annual, 2025-12-31) — Deferred Income Tax: 122000000.00
CNP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 38000000.00
CNP cash_flow (annual, 2025-12-31) — Deferred Tax: 122000000.00
CNP cash_flow (quarterly, 2025-12-31) — Deferred Tax: 38000000.00
CNP cash_flow (annual, 2025-12-31) — Depreciation: 1256000000.00
CNP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1530000000.00
CNP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 405000000.00
CNP income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1530000000.00
CNP income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 405000000.00
CNP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1530000000.00
CNP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 405000000.00
CNP income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1530000000.00
CNP income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 405000000.00
CNP income_statement (annual, 2025-12-31) — Diluted Average Shares: 656000000.00
CNP income_statement (annual, 2025-12-31) — Diluted EPS: 1.60
CNP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 264000000.00
CNP balance_sheet (annual, 2025-12-31) — Dividends Payable: 150000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 150000000.00
CNP income_statement (annual, 2025-12-31) — EBIT: 2150000000.00
CNP income_statement (quarterly, 2025-12-31) — EBIT: 557000000.00
CNP income_statement (annual, 2025-12-31) — EBITDA: 3680000000.00
CNP income_statement (quarterly, 2025-12-31) — EBITDA: 962000000.00
CNP balance_sheet (annual, 2025-12-31) — Employee Benefits: 491000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 491000000.00
CNP cash_flow (annual, 2025-12-31) — End Cash Position: 49000000.00
CNP cash_flow (quarterly, 2025-12-31) — End Cash Position: 49000000.00
CNP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1549000000.00
CNP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 644000000.00
CNP cash_flow (annual, 2025-12-31) — Free Cash Flow: -2384000000.00
CNP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -707000000.00
CNP cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4000000.00
CNP cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -2000000.00
CNP cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 49000000.00
CNP income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -49000000.00
CNP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: -6000000.00
CNP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 4000000.00
CNP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 2000000.00
CNP balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -26000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -26000000.00
CNP balance_sheet (annual, 2025-12-31) — Goodwill: 3550000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Goodwill: 3550000000.00
CNP balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 3550000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 3550000000.00
CNP balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 831000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 831000000.00
CNP balance_sheet (annual, 2025-12-31) — Gross PPE: 44676000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 44676000000.00
CNP income_statement (annual, 2025-12-31) — Gross Profit: 4216000000.00
CNP income_statement (quarterly, 2025-12-31) — Gross Profit: 1096000000.00
CNP income_statement (annual, 2025-12-31) — Interest Expense: 903000000.00
CNP income_statement (quarterly, 2025-12-31) — Interest Expense: 227000000.00
CNP income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 903000000.00
CNP income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 227000000.00
CNP cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 983000000.00
CNP cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 220000000.00
CNP balance_sheet (annual, 2025-12-31) — Interest Payable: 313000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Interest Payable: 313000000.00
CNP balance_sheet (annual, 2025-12-31) — Inventory: 732000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Inventory: 732000000.00
CNP balance_sheet (annual, 2025-12-31) — Invested Capital: 34133000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 34133000000.00
CNP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4016000000.00
CNP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1414000000.00
CNP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3714000000.00
CNP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 862000000.00
CNP balance_sheet (annual, 2025-12-31) — Long Term Debt: 20566000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 20566000000.00
CNP balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 20566000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 20566000000.00
CNP cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3714000000.00
CNP cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 862000000.00
CNP cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1579000000.00
CNP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -101000000.00
CNP cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 862000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -357000000.00
CNP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CNP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CNP balance_sheet (annual, 2025-12-31) — Net Debt: 22942000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Net Debt: 22942000000.00
CNP income_statement (annual, 2025-12-31) — Net Income: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 264000000.00
CNP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1052000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1052000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 264000000.00
CNP income_statement (annual, 2025-12-31) — Net Interest Income: -903000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Interest Income: -227000000.00
CNP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2130000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 759000000.00
CNP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2135000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 761000000.00
CNP income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -903000000.00
CNP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -227000000.00
CNP cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -7000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 28000000.00
CNP cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -8000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 424000000.00
CNP balance_sheet (annual, 2025-12-31) — Net PPE: 34056000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Net PPE: 34056000000.00
CNP cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
CNP cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -5000000.00
CNP cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -2000000.00
CNP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 7603000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 7603000000.00
CNP balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 4602000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 4602000000.00
CNP balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 4602000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 4602000000.00
CNP balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 491000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 491000000.00
CNP income_statement (annual, 2025-12-31) — Normalized EBITDA: 3725000000.00
CNP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 966000000.00
CNP income_statement (annual, 2025-12-31) — Normalized Income: 1089800000.00
CNP income_statement (quarterly, 2025-12-31) — Normalized Income: 267200000.00
CNP cash_flow (annual, 2025-12-31) — Operating Cash Flow: 2486000000.00
CNP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 774000000.00
CNP cash_flow (annual, 2025-12-31) — Operating Gains Losses: 45000000.00
CNP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 4000000.00
CNP income_statement (annual, 2025-12-31) — Operating Income: 2110000000.00
CNP income_statement (quarterly, 2025-12-31) — Operating Income: 542000000.00
CNP income_statement (annual, 2025-12-31) — Operating Revenue: 9357000000.00
CNP income_statement (quarterly, 2025-12-31) — Operating Revenue: 2505000000.00
CNP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 652869575.00
CNP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 652869575.00
CNP balance_sheet (annual, 2025-12-31) — Other Current Assets: 310000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 310000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 2414000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 2414000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1650000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1650000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -26000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -26000000.00
CNP income_statement (annual, 2025-12-31) — Other Income Expense: 40000000.00
CNP income_statement (quarterly, 2025-12-31) — Other Income Expense: 15000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Inventories: 215000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Inventories: 215000000.00
CNP cash_flow (annual, 2025-12-31) — Other Non Cash Items: -214000000.00
CNP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -49000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 222000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 222000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 770000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 770000000.00
CNP income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 85000000.00
CNP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 19000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Properties: 3956000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Properties: 3956000000.00
CNP balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 510000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 510000000.00
CNP income_statement (annual, 2025-12-31) — Other Taxes: 576000000.00
CNP income_statement (quarterly, 2025-12-31) — Other Taxes: 149000000.00
CNP balance_sheet (annual, 2025-12-31) — Payables: 1794000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Payables: 1794000000.00
CNP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2107000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2107000000.00
CNP cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: 0.00
CNP cash_flow (annual, 2025-12-31) — Preferred Stock Payments: 0.00
CNP income_statement (annual, 2025-12-31) — Pretax Income: 1247000000.00
CNP income_statement (quarterly, 2025-12-31) — Pretax Income: 330000000.00
CNP cash_flow (annual, 2025-12-31) — Purchase Of Business: -357000000.00
CNP balance_sheet (annual, 2025-12-31) — Receivables: 1442000000.00
CNP balance_sheet (quarterly, 2025-12-31) — Receivables: 1442000000.00
CNP income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5141000000.00
CNP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1409000000.00
CNP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1530000000.00
CNP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 405000000.00